These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22418063)

  • 1. Gene delivery technologies for cardiac applications.
    Katz MG; Fargnoli AS; Pritchette LA; Bridges CR
    Gene Ther; 2012 Jun; 19(6):659-69. PubMed ID: 22418063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in Gene Therapy for Chronic Heart Failure.
    Yin ZQ; Xing WH
    Heart Surg Forum; 2018 Mar; 21(2):E075-E083. PubMed ID: 29658862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene delivery methods in cardiac gene therapy.
    Ishikawa K; Tilemann L; Fish K; Hajjar RJ
    J Gene Med; 2011 Oct; 13(10):566-72. PubMed ID: 21954037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in gene-based therapy for heart failure.
    Ly HQ; Kawase Y; Hajjar RJ
    J Cardiovasc Transl Res; 2008 Jun; 1(2):127-36. PubMed ID: 20559907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A translatable, closed recirculation system for AAV6 vector-mediated myocardial gene delivery in the large animal.
    Swain JD; Katz MG; White JD; Thesier DM; Henderson A; Stedman HH; Bridges CR
    Methods Mol Biol; 2011; 709():331-54. PubMed ID: 21194039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene targeting in ischemic heart disease and failure: translational and clinical studies.
    Eckhouse SR; Jones JA; Spinale FG
    Biochem Pharmacol; 2013 Jan; 85(1):1-11. PubMed ID: 22935384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic editing of dysfunctional myocardium.
    Hajjar RJ; Huq F; Matsui T; Rosenzweig A
    Med Clin North Am; 2003 Mar; 87(2):553-67. PubMed ID: 12693739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GENE THERAPY POTENTIAL AS A TREATMENT FOR HEART FAILURE].
    Katz MG; Hadas Y; Fargnoli AS; Hadas S; Zangi L; Bridges CR
    Harefuah; 2018 Feb; 157(2):112-116. PubMed ID: 29484868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure.
    Hajjar RJ; Zsebo K; Deckelbaum L; Thompson C; Rudy J; Yaroshinsky A; Ly H; Kawase Y; Wagner K; Borow K; Jaski B; London B; Greenberg B; Pauly DF; Patten R; Starling R; Mancini D; Jessup M
    J Card Fail; 2008 Jun; 14(5):355-67. PubMed ID: 18514926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Cardiac Surgery with Recirculating Delivery (MCARD): Procedure and Vector Transfer.
    Katz MG; Fargnoli AS; Kendle AP; Bridges CR
    Methods Mol Biol; 2017; 1521():271-289. PubMed ID: 27910057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
    Fish KM; Ladage D; Kawase Y; Karakikes I; Jeong D; Ly H; Ishikawa K; Hadri L; Tilemann L; Muller-Ehmsen J; Samulski RJ; Kranias EG; Hajjar RJ
    Circ Heart Fail; 2013 Mar; 6(2):310-7. PubMed ID: 23271792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin 3 Gene Transfer Increases Function of the Failing Murine Heart.
    Giamouridis D; Gao MH; Lai NC; Tan Z; Kim YC; Guo T; Miyanohara A; Blankesteijn MW; Biessen EAL; Hammond HK
    Hum Gene Ther; 2019 Jan; 30(1):10-20. PubMed ID: 30003813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases. Approaches and perspectives.
    Poller W; Fechner H; Kurreck J; Pauschinger M; Kühl U; Erdmann VA; Lamers JM; Schultheiss HP
    Z Kardiol; 2004 Mar; 93(3):171-93. PubMed ID: 15024585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery.
    Maurice JP; Hata JA; Shah AS; White DC; McDonald PH; Dolber PC; Wilson KH; Lefkowitz RJ; Glower DD; Koch WJ
    J Clin Invest; 1999 Jul; 104(1):21-9. PubMed ID: 10393695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer for congestive heart failure: update 2013.
    Tang T; Hammond HK
    Transl Res; 2013 Apr; 161(4):313-20. PubMed ID: 23261978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral Gene Transfer of Gremlin Modulates Vascular Endothelial Growth Factor-A-Induced Angiogenesis in Porcine Myocardium.
    Pajula JJ; Halonen PJ; Hätinen OP; Ylä-Herttuala S; Nurro J
    Hum Gene Ther; 2020 Feb; 31(3-4):211-218. PubMed ID: 31884825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Method of gene delivery in large animal models of cardiovascular diseases.
    Kawase Y; Ladage D; Hajjar RJ
    Methods Mol Biol; 2011; 709():355-67. PubMed ID: 21194040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous approaches for efficient cardiac gene delivery.
    Ishikawa K; Aguero J; Naim C; Fish K; Hajjar RJ
    J Cardiovasc Transl Res; 2013 Aug; 6(4):649-59. PubMed ID: 23749638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac gene therapy: from concept to reality.
    Kratlian RG; Hajjar RJ
    Curr Heart Fail Rep; 2012 Mar; 9(1):33-9. PubMed ID: 22143928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.